MELISSA DECELLES: Open Payments
NPI 1689453714 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$757 in 31 payments from 17 companies in 2025. Trend: 2023 $13 · 2024 $859 · 2025 $757
Food & beverage: $757
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $170 |
| Novartis Pharmaceuticals Corporation | 4 | $74 |
| Janssen Biotech, Inc. | 3 | $68 |
| Astellas Pharma US Inc | 2 | $64 |
| Sumitomo Pharma America, Inc. | 2 | $51 |
| Incyte Corporation | 2 | $46 |
| Genentech USA, Inc. | 2 | $45 |
| SOBI, INC | 1 | $31 |
| Daiichi Sankyo Inc. | 1 | $30 |
| TerSera Therapeutics LLC | 1 | $30 |
Products named: EPKINLY, Padcev, KISQALI, ENHERTU, ORGOVYX, RYBREVANT, Vonjo, Vyloy.
Industry payments across CO — which companies pay providers there.
